KLI

Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A

Metadata Downloads
Publisher
Thoracic Cancer
Language
영어
ISSN
1759-7706
Citation Volume
12
Citation Number
4
Citation Start Page
444
Citation End Page
452
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.